Massachusetts General Hospital has begun performing digitally controlled catheter-based interventions using Siemens' Axiom Artis dFC Magnetic Navigation. The system integrates Siemens' flat-detector fluoroscopic imaging system, the Artis dFC, with
Massachusetts General Hospital has begun performing digitally controlled catheter-based interventions using Siemens' Axiom Artis dFC Magnetic Navigation. The system integrates Siemens' flat-detector fluoroscopic imaging system, the Artis dFC, with Stereotaxis' Niobe Magnetic Navigation System to navigate catheters and guidewires to target sites in the heart and coronary vasculature. Computer-controlled permanent magnets, external to the body, orient the magnetic tip of specially designed catheters and guidewires. The system promises to increase efficiency, enhance productivity, and help clinicians improve the ease and accuracy of catheter-based procedures.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
2 Commerce Drive
Cranbury, NJ 08512